Labor Dystocia
Conditions
Keywords
dilation, labor
Brief summary
The purpose of this study is to is to determine the clinical effectiveness of a single dose of intravenous (IV) medication for the prevention of labor arrest and cesarean delivery in primiparous women undergoing trial of labor.
Interventions
Diphenhydramine 50mg IV will be administered within 1 hour of the cervical exam which diagnosed prolonged active phase of labor
Participants will receive cervical exams every 2 hours in active labor, placement of intrauterine pressure catheter, up titration of Pitocin if contractions are inadequate, maternal repositioning, and use of adjunct devices such as a peanut ball.
Sponsors
Study design
Eligibility
Inclusion criteria
* Primiparous * Viable single intrauterine pregnancy -≥ 34 weeks of gestation * Ruptured membranes * Category I tracing at time of inclusion * Active phase of labor (\>=6 cm of cervix dilation)
Exclusion criteria
* Category II or III tracing * Allergy to the study medication (IV Diphenhydramine)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of participants that achieve complete dilation of cervix (10cm) | from start of treatment upto 4 hours |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants who have vaginal delivery after protracted labor | End of delivery (an average of upto 6 hours after start of treatment) | — |
| Number of participants who have Postpartum complications captured as composite maternal morbidity | from hospitalization up to 6 weeks postpartum | This includes postpartum hemorrhage, cervical lacerations or intraamniotic infection |
| Number of neonates that had adverse events | from birth up to 6 weeks post-delivery | Adverse events include 5 minute APGAR SCORES less than 7, Respiratory Support with intubation in the delivery room , Neonatal intensive acre unit (NICU) admission, Fetal Anomalies, Infection, Intraventricular Hemorrhage, Hypoglycemia, Retinopathy of prematurity, Injuries, Fractures |
Countries
United States
Contacts
The University of Texas Health Science Center, Houston